Related references
Note: Only part of the references are listed.EJC's biennial report on metastatic soft tissue sarcoma: State of the art and future perspectives
Melissa Vos et al.
EUROPEAN JOURNAL OF CANCER (2018)
Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
Lars H. Lindner et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg 51, 2018)
P. G. Casali et al.
ANNALS OF ONCOLOGY (2018)
Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts
Winette T. A. van der Graaf et al.
LANCET ONCOLOGY (2017)
Survival and prognostic factors following pulmonary metastasectomy for sarcoma
Giuseppe Marulli et al.
JOURNAL OF THORACIC DISEASE (2017)
Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study
Marion Savina et al.
BMC MEDICINE (2017)
Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072
B. Kasper et al.
ANNALS OF ONCOLOGY (2014)
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali et al.
ANNALS OF ONCOLOGY (2014)
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial
B. Bui-Nguyen et al.
ANNALS OF ONCOLOGY (2012)
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
Stefan Sleijfer et al.
EUROPEAN JOURNAL OF CANCER (2010)
Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
Isabelle Ray-Coquard et al.
CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma
Shailendra Verma et al.
CANCER TREATMENT REVIEWS (2008)
Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy
JY Blay et al.
EUROPEAN JOURNAL OF CANCER (2003)
Prognostic factors in soft tissue sarcomas: a study of 395 patients
PD Stefanovski et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2002)
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults
JY Blay et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
A Le Cesne et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
